Lynda Scammell, the head of borderline products at the MHRA, said: Peptide products may be sold as cosmetics, supplements and medicines, and depending on their intended purpose, they fall under different regulatory frameworks
The good news is GLP-1s are becoming more available with new oral preparations commercially availability
Used worldwide to treat severe inflammation, allergic reactions, immune disorders, asthma, shock, and COVID-19 complications, this fast-acting injectable is hospital-grade and ready for urgent or routine use
Drug reimbursement is calculated separately through the J-code at Average Sales Price plus 6%
however, anytime you receive an injection theres a slight risk of allergic reaction